Breakthroughs in treatments and medications highlight the annual MauiDerm conference, as well as dozens of sessions and workshops, Q&A with industry leaders, a reception devoted to women in dermatology, and the Alan Shalita Memorial Lecture.
Emerging therapies for rosacea have a favorable side effect profile and address specific symptoms of the condition; brimonidine, for example, addresses background erythema while ivermectin addresses the papules and pustules.
Treating common skin conditions such as rosacea and melasma with appropriate topical agents, chemical peels, devices and cosmeceuticals can build trust among patients who may require additional dermatological services, experts say.
Years ago, Mark Dunbar, OD, FAAO, of Bascom Palmer shared with me some cases about rosacea. I was a little taken aback because the cases he shared concerned Hispanic patients, not the usual patients of Northern English isles descent we read about in school. The skeptic in me was doubtful, even though Mark had great pictures and detailed data from the cases.
Lead author and a Galderma consultant dermatologist Linda Stein Gold, M.D. writes to Dermatology Times that results from Soolantra (ivermectin) Cream, 1% were seen in clinical studies as early as week two, with continuous improvement in patients with inflammatory lesions of rosacea.